The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | COM | 00461U105 | 25,770 | 1,022,612 | SH | SOLE | 1,022,612 | 0 | 0 | 0 | |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 6,999 | 883,720 | SH | SOLE | 883,720 | 0 | 0 | 0 | |
Albireo Pharma, Inc. | COM | 01345P106 | 3,525 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | 0 | |
Allakos Inc | COM | 01671P100 | 16,788 | 146,259 | SH | SOLE | 146,259 | 0 | 0 | 0 | |
Allakos Inc | COM | 01671P100 | 9,527 | 83,000 | SH | Call | SOLE | 83,000 | 0 | 0 | 0 |
Allovir, Inc | COM | 019818103 | 1,927 | 82,336 | SH | SOLE | 82,336 | 0 | 0 | 0 | |
Alpine Immune Sciences Inc | COM | 02083G100 | 4,231 | 399,190 | SH | SOLE | 399,190 | 0 | 0 | 0 | |
Amarin Corp PLC | SPONS ADR NEW | 023111206 | 155 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | 0 | |
Atreca Inc | COM | 04965G109 | 6,083 | 396,835 | SH | SOLE | 396,835 | 0 | 0 | 0 | |
Avadel Pharmaceuticals PLC | SPONS ADR | 05337M104 | 4,965 | 549,250 | SH | SOLE | 549,250 | 0 | 0 | 0 | |
BCLS Acquisition Corp | COM | G0904B105 | 3,171 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | 0 | |
BCTG Acquisition Corp | COM | 05492W103 | 5,560 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | 0 | |
BioNTech SE | SPONS ADS | 09075V102 | 1,179 | 10,795 | SH | SOLE | 10,795 | 0 | 0 | 0 | |
Bolt Biotherapeutics, Inc | COM | 097702104 | 24,270 | 737,459 | SH | SOLE | 737,459 | 0 | 0 | 0 | |
Catabasis Pharmaceuticals Inc | COM | 14875P206 | 434 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | 0 | |
Chinook Therapeutics Inc | COM | 16961L106 | 49,237 | 3,168,388 | SH | SOLE | 3,168,388 | 0 | 0 | 0 | |
Consonance HFW Acquisition Co | COM | G2445M129 | 2,928 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | 0 | |
CureVac N.V. | COM | N2451R105 | 8,718 | 95,318 | SH | SOLE | 95,318 | 0 | 0 | 0 | |
Decibel Therapeutics Inc | COM | 24343R106 | 9,388 | 826,422 | SH | SOLE | 826,422 | 0 | 0 | 0 | |
Equillium, Inc. | COM | 29446K106 | 5,465 | 764,403 | SH | SOLE | 764,403 | 0 | 0 | 0 | |
Eyepoint Pharmaceuticals Inc | COM | 30233G209 | 4,572 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | 0 | |
Forma Therapeutics Holdings, Inc. | COM | 34633R104 | 43,866 | 1,565,529 | SH | SOLE | 1,565,529 | 0 | 0 | 0 | |
Immunocore Holdings Limited | SPONS ADS | 45258D105 | 3,406 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | 0 | |
Instil Bio Inc | COM | 45783C101 | 38,975 | 1,554,025 | SH | SOLE | 1,554,025 | 0 | 0 | 0 | |
Intercept Pharmaceuticals Inc | COM | 45845P108 | 14,787 | 640,688 | SH | SOLE | 640,688 | 0 | 0 | 0 | |
Iveric Bio, Inc. | COM | 46583P102 | 14,664 | 2,372,476 | SH | SOLE | 2,372,476 | 0 | 0 | 0 | |
Jiya Acquisition Corp | COM | 47760M102 | 4,989 | 507,041 | SH | SOLE | 507,041 | 0 | 0 | 0 | |
Kala Pharmaceuticals Inc | COM | 483119103 | 4,052 | 601,162 | SH | SOLE | 601,162 | 0 | 0 | 0 | |
Kronos Bio Inc | COM | 50107A104 | 4,866 | 166,250 | SH | SOLE | 166,250 | 0 | 0 | 0 | |
Lifesci Acquisition II Corp | COM | 53229E103 | 2,028 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | 0 | |
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 530 | 18,225 | SH | SOLE | 18,225 | 0 | 0 | 0 | |
Nkarta, Inc. | COM | 65487U108 | 66,942 | 2,034,703 | SH | SOLE | 2,034,703 | 0 | 0 | 0 | |
Novavax, Inc. | COM | 670002401 | 5,468 | 30,160 | SH | SOLE | 30,160 | 0 | 0 | 0 | |
Novavax, Inc. | COM | 670002401 | 36,008 | 198,600 | SH | Call | SOLE | 198,600 | 0 | 0 | 0 |
Odonate Therapeutics Inc | COM | 676079106 | 2,395 | 700,421 | SH | SOLE | 700,421 | 0 | 0 | 0 | |
Rhythm Pharmaceuticals Inc | COM | 76243J105 | 4,276 | 201,046 | SH | SOLE | 201,046 | 0 | 0 | 0 | |
Rocket Pharmaceuticals Inc | COM | 77313F106 | 2,829 | 63,770 | SH | SOLE | 63,770 | 0 | 0 | 0 | |
Springworks Therapeutics Inc | COM | 85205L107 | 12,496 | 169,852 | SH | SOLE | 169,852 | 0 | 0 | 0 | |
Sutro BioPharma Inc | COM | 869367102 | 38,136 | 1,675,579 | SH | SOLE | 1,675,579 | 0 | 0 | 0 | |
Syros Pharmaceuticals Inc | COM | 87184Q107 | 14,769 | 2,189,199 | SH | SOLE | 2,189,199 | 0 | 0 | 0 | |
Terns Pharmaceuticals, Inc | COM | 880881107 | 10,946 | 497,555 | SH | SOLE | 497,555 | 0 | 0 | 0 | |
Viracta Therapeutics Inc | COM | 92765F108 | 7,693 | 831,625 | SH | SOLE | 831,625 | 0 | 0 | 0 | |
Vistagen Therapeutics Inc | COM | 92840H202 | 3,901 | 1,831,490 | SH | SOLE | 1,831,490 | 0 | 0 | 0 | |
Verona Pharma PLC. | SPONS ADS | 925050106 | 9,289 | 1,111,112 | SH | SOLE | 1,111,112 | 0 | 0 | 0 |